↓ Skip to main content

Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan

Overview of attention for article published in Arthritis Research & Therapy, March 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

news
3 news outlets
policy
1 policy source

Citations

dimensions_citation
31 Dimensions

Readers on

mendeley
60 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan
Published in
Arthritis Research & Therapy, March 2019
DOI 10.1186/s13075-019-1856-4
Pubmed ID
Authors

Yoshiya Tanaka, Kazuteru Wada, Yoshinori Takahashi, Owen Hagino, Hubert van Hoogstraten, Neil M. H. Graham, Hideto Kameda

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 60 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 60 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 9 15%
Student > Ph. D. Student 5 8%
Other 4 7%
Student > Doctoral Student 4 7%
Student > Bachelor 4 7%
Other 12 20%
Unknown 22 37%
Readers by discipline Count As %
Medicine and Dentistry 12 20%
Pharmacology, Toxicology and Pharmaceutical Science 9 15%
Nursing and Health Professions 4 7%
Arts and Humanities 1 2%
Business, Management and Accounting 1 2%
Other 6 10%
Unknown 27 45%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 24. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 January 2021.
All research outputs
#1,551,104
of 25,385,509 outputs
Outputs from Arthritis Research & Therapy
#195
of 3,381 outputs
Outputs of similar age
#35,546
of 364,003 outputs
Outputs of similar age from Arthritis Research & Therapy
#12
of 57 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,381 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.2. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 364,003 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 57 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.